Andrew Thome, MD
Foot and Ankle Surgery · Saint Louis, MONPI 1326426925
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (41.6%), food and beverage and education — rather than concentrated in one kind of arrangement. Arthrex accounts for 61.7% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2022 at $17,050 and has fallen 94.1% since, to $1,012 in 2025.
Across 120 payments — averaging $200.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$15K
- Stryker$4K
- Pylant Medical$1K
- Elite Orthopedics, LLC$864
- Paragon 28, Inc.$828
- Medical Device Business Services, Inc.$738
- plus $2K from 12 others
What the payments were for
- Grants$10,00042%
- Travel & lodging$2,2059%
- Food & beverage$6,28626%
- Education$5,53823%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 19 | $14,829 |
| Stryker | 57 | $3,909 |
| Pylant Medical | 2 | $1,222 |
| Elite Orthopedics, LLC | 13 | $864 |
| Paragon 28, Inc. | 4 | $828 |
| Medical Device Business Services, Inc. | 3 | $738 |
| Johnson & Johnson | 7 | $462 |
| Zimmer Biomet | 2 | $259 |
| Linvatec Corporation | 2 | $241 |
| Medline Industries LP | 2 | $185 |
| Acera Surgical, Inc. | 1 | $139 |
| Orthofix Medical, Inc. | 1 | $102 |
| Smith+Nephew | 1 | $90 |
| DJO, LLC | 1 | $77 |
| Treace Medical Concepts, Inc. | 2 | $30 |
| Zimvie Inc. | 1 | $21 |
| Heron Therapeutics, Inc. | 1 | $19 |
| Merck | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$766
- AUGMENT INJECTABLE$723
- SALVATION$578
- Phantom Fibula Nail$578
- PROstep$465
- ORTHOLOC 2 LAPIFUSE$465
- NA$447
- PROPHECY$350
- BIO4$304
- TRITANIUM$259
- BioBrace 23mm$241
- VITOSS$170
- CASCADIA INTERBODY SYSTEM$165
- A3$162
- YUKON$158
- INBONE$157
- Affixus$145
- Alps Clavicle$145
- Restrata Wound Matrix$139
- SILVERBACK$136
How this compares
$24,029 in reported general payments places this provider in the 85th percentile of 163 foot and ankle surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 20 | $83 |
| Ondansetron Hcl | 15 | $45 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Saint Louis
- Jeremy McCormickSaint Louis$1.5M
- Jeffrey JohnsonSaint Louis$944K
- Raymond AbdoSaint Louis$251K
- Vincent SollecitoSaint Louis$221K
- John HoltzmanSaint Louis$129K
- Jesse WolfeSaint Louis$89K
- Seth AndersonSaint Louis$45K
- Kelly HynesSaint Louis$34K
- Lindsay BarthSaint Louis$30K
- Timothy OldaniSaint Louis$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.